The collaboration between Enzymit and Aleph Farms holds immense potential for the cultivation of cow cells as well as extending to other cultivated meat types.
Marking a significant leap in the animal-free meat industry, bioproduction platform company Enzymit and food-tech company Aleph Farms have collaborated to successfully develop insulin substituents that have the potential to revolutionize the production of cultivated meat at scale, by significantly reducing costs and development time.
Scaling up cultivated meat production has until now been hindered by the high expenses associated with developing non-animal-derived serum protein mimetics. These proteins play a crucial role in promoting and supporting cell growth but are currently not readily available in the market at the necessary quantity, quality, and cost for large-scale production.
** Click here to read the full-text **
